PIKfyve upregulates CFTR activity

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 952-957

  Gehring, Eva Maria ^a   Lam, Rebecca S ^a,b   Siraskar, Gulab ^a   Koutsouki, Evgenia ^b   Seebohm, Guiscard ^a,c   Ureche, Oana N ^a   Ureche, Liviu ^a   Baltaev, Ravshan ^a   Tavare, Jeremy M ^d   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

cAMP; Cl channels; Phosphatidylinositides; Trafficking

Indexed keywords

CHLORIDE CHANNEL; FORSKOLIN; GLUCOSE TRANSPORTER; ISOBUTYLMETHYLXANTHINE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE 5 KINASE; PROTEIN KINASE B; REGULATOR PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VOLTAGE CLAMP; XENOPUS LAEVIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; OOCYTES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TWO-HYBRID SYSTEM TECHNIQUES; UP-REGULATION; XENOPUS LAEVIS;

EID: 70449720495     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.084     Document Type: Article

References (46)

1. Quinton P.M. Sweating and its disorders. Annu. Rev. Med. 34 (1983) 429-452
2. Sheppard D.N., and Welsh M.J. Structure and function of the CFTR chloride channel. Physiol. Rev. 79 (1999) S23-S45
3. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., and Chou J.L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
4. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O'Riordan C.R., and Smith A.E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63 (1990) 827-834
5. Michell R.H., Heath V.L., Lemmon M.A., and Dove S.K. Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions. Trends Biochem. Sci. 31 (2006) 52-63
6. Bazenet C.E., Ruano A.R., Brockman J.L., and Anderson R.A. The human erythrocyte contains two forms of phosphatidylinositol-4-phosphate 5-kinase which are differentially active toward membranes. J. Biol. Chem. 265 (1990) 18012-18022
7. Cabezas A., Pattni K., and Stenmark H. Cloning and subcellular localization of a human phosphatidylinositol 3-phosphate 5-kinase, PIKfyve/Fab1. Gene 371 (2006) 34-41
8. Sbrissa D., Ikonomov O.C., and Shisheva A. PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J. Biol. Chem. 274 (1999) 21589-21597
9. Sbrissa D., Ikonomov O.C., and Shisheva A. Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomembrane localization. J. Biol. Chem. 277 (2002) 6073-6079
10. Gillooly D.J., Morrow I.C., Lindsay M., Gould R., Bryant N.J., Gaullier J.M., Parton R.G., and Stenmark H. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 19 (2000) 4577-4588
11. 2+-binding FYVE finger-containing phosphoinositide kinase in insulin-sensitive cells. Mol. Cell. Biol. 19 (1999) 623-634
12. Rutherford A.C., Traer C., Wassmer T., Pattni K., Bujny M.V., Carlton J.G., Stenmark H., and Cullen P.J. The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport. J. Cell Sci. 119 (2006) 3944-3957
13. Rusten T.E., Rodahl L.M., Pattni K., Englund C., Samakovlis C., Dove S., Brech A., and Stenmark H. Fab1 phosphatidylinositol 3-phosphate 5-kinase controls trafficking but not silencing of endocytosed receptors. Mol. Biol. Cell 17 (2006) 3989-4001
14. Botelho R.J. Changing phosphoinositides "on the fly": how trafficking vesicles avoid an identity crisis. Bioessays 31 (2009) 1127-1136
15. de Lartigue J., Polson H., Feldman M., Shokat K., Tooze S.A., Urbe S., and Clague M.J. PIKfyve regulation of endosome-linked pathways. Traffic 10 (2009) 883-893
16. Shisheva A. PIKfyve: partners, significance, debates and paradoxes. Cell Biol. Int. 32 (2008) 591-604
17. Ikonomov O.C., Fligger J., Sbrissa D., Dondapati R., Mlak K., Deeb R., and Shisheva A. Kinesin adapter JLP links PIKfyve to microtubule-based endosome-to-trans-Golgi network traffic of furin. J. Biol. Chem. 284 (2009) 3750-3761
18. Berwick D.C., Dell G.C., Welsh G.I., Heesom K.J., Hers I., Fletcher L.M., Cooke F.T., and Tavare J.M. Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. J. Cell Sci. 117 (2004) 5985-5993
19. Shojaiefard M., Strutz-Seebohm N., Tavare J.M., Seebohm G., and Lang F. Regulation of the Na(+), glucose cotransporter by PIKfyve and the serum and glucocorticoid inducible kinase SGK1. Biochem. Biophys. Res. Commun. 359 (2007) 843-847
20. Ikonomov O.C., Sbrissa D., and Shisheva A. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem. Biophys. Res. Commun. 382 (2009) 566-570
21. Klaus F., Gehring E.M., Zurn A., Laufer J., Lindner R., Strutz-Seebohm N., Tavare J.M., Rothstein J.D., Boehmer C., Palmada M., Gruner I., Lang U.E., Seebohm G., and Lang F. Regulation of the Na(+)-coupled glutamate transporter EAAT3 by PIKfyve. Neurochem. Int. 54 (2009) 372-377
22. Strutz-Seebohm N., Shojaiefard M., Christie D., Tavare J., Seebohm G., and Lang F. PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8. Cell. Physiol. Biochem. 20 (2007) 729-734
23. Seebohm G., Strutz-Seebohm N., Birkin R., Dell G., Bucci C., Spinosa M.R., Baltaev R., Mack A.F., Korniychuk G., Choudhury A., Marks D., Pagano R.E., Attali B., Pfeufer A., Kass R.S., Sanguinetti M.C., Tavare J.M., and Lang F. Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels. Circ. Res. 100 (2007) 686-692
24. -2. Biochem. Biophys. Res. Commun. 381 (2009) 407-411
25. Koutsouki E., Lam R.S., Seebohm G., Ureche O.N., Ureche L., Baltaev R., and Lang F. Modulation of human Kv1.5 channel kinetics by N-cadherin. Biochem. Biophys. Res. Commun. 363 (2007) 18-23
26. Schorderet-Slatkine S., and Baulieu E.E. Forskolin increases cAMP and inhibits progesterone induced meiosis reinitiation in Xenopus laevis oocytes. Endocrinology 111 (1982) 1385-1387
27. Barish M.E. A transient calcium-dependent chloride current in the immature Xenopus oocyte. J. Physiol. 342 (1983) 309-325
28. Lamprecht G., and Seidler U. The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G766-G777
29. Lee J.H., Richter W., Namkung W., Kim K.H., Kim E., Conti M., and Lee M.G. Dynamic regulation of cystic fibrosis transmembrane conductance regulator by competitive interactions of molecular adaptors. J. Biol. Chem. 282 (2007) 10414-10422
30. Li C., Dandridge K.S., Di A., Marrs K.L., Harris E.L., Roy K., Jackson J.S., Makarova N.V., Fujiwara Y., Farrar P.L., Nelson D.J., Tigyi G.J., and Naren A.P. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J. Exp. Med. 202 (2005) 975-986
31. Sonawane N.D., Hu J., Muanprasat C., and Verkman A.S. Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera. FASEB J. 20 (2006) 130-132
32. Morris A.J. Regulation of phospholipase D activity, membrane targeting and intracellular trafficking by phosphoinositides. Biochem. Soc. Symp. (2007) 247-257
33. Zheng Q., and Bobich J.A. ADP-ribosylation factor6 regulates both [3H]-noradrenaline and [14C]-glutamate exocytosis through phosphatidylinositol 4,5-bisphosphate. Neurochem. Int. 45 (2004) 633-640
34. Himmel B., and Nagel G. Protein kinase-independent activation of CFTR by phosphatidylinositol phosphates. EMBO Rep. 5 (2004) 85-90
35. Kim J., Jahng W.J., Di Vizio D., Lee J.S., Jhaveri R., Rubin M.A., Shisheva A., and Freeman M.R. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res. 67 (2007) 9229-9237
36. Saxena S.K., Kaur S., and George C. Rab4GTPase modulates CFTR function by impairing channel expression at plasma membrane. Biochem. Biophys. Res. Commun. 341 (2006) 184-191
37. Gentzsch M., Chang X.B., Cui L., Wu Y., Ozols V.V., Choudhury A., Pagano R.E., and Riordan J.R. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15 (2004) 2684-2696
38. Swiatecka-Urban A., Brown A., Moreau-Marquis S., Renuka J., Coutermarsh B., Barnaby R., Karlson K.H., Flotte T.R., Fukuda M., Langford G.M., and Stanton B.A. The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells. J. Biol. Chem. 280 (2005) 36762-36772
39. Saxena S.K., and Kaur S. Rab27a negatively regulates CFTR chloride channel function in colonic epithelia: involvement of the effector proteins in the regulatory mechanism. Biochem. Biophys. Res. Commun. 346 (2006) 259-267
40. Ikonomov O.C., Sbrissa D., Mlak K., Deeb R., Fligger J., Soans A., Finley Jr. R.L., and Shisheva A. Active PIKfyve associates with and promotes the membrane attachment of the late endosome-to-trans-Golgi network transport factor Rab9 effector p40. J. Biol. Chem. 278 (2003) 50863-50871
41. Sbrissa D., Ikonomov O.C., and Shisheva A. Analysis of potential binding of the recombinant Rab9 effector p40 to phosphoinositide-enriched synthetic liposomes. Methods Enzymol. 403 (2005) 696-705
42. Lombardi D., Soldati T., Riederer M.A., Goda Y., Zerial M., and Pfeffer S.R. Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J. 12 (1993) 677-682
43. Murray J.L., Mavrakis M., McDonald N.J., Yilla M., Sheng J., Bellini W.J., Zhao L., Le Doux J.M., Shaw M.W., Luo C.C., Lippincott-Schwartz J., Sanchez A., Rubin D.H., and Hodge T.W. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J. Virol. 79 (2005) 11742-11751
44. Wagner C.A., Ott M., Klingel K., Beck S., Melzig J., Friedrich B., Wild K.N., Broer S., Moschen I., Albers A., Waldegger S., Tummler B., Egan M.E., Geibel J.P., Kandolf R., and Lang F. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis. Cell. Physiol. Biochem. 11 (2001) 209-218
45. Sato J.D., Chapline M.C., Thibodeau R., Frizzell R.A., and Stanton B.A. Regulation of human cystic fibrosis transmembrane conductance regulator (CFTR) by serum- and glucocorticoid-inducible kinase (SGK1). Cell. Physiol. Biochem. 20 (2007) 91-98
46. Kobayashi T., Deak M., Morrice N., and Cohen P. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Biochem. J. 344 (1999) 189-197